Literature DB >> 12109904

Synthesis and effects on chloroquine susceptibility in Plasmodium falciparum of a series of new dihydroanthracene derivatives.

Sandrine Alibert1, Christiane Santelli-Rouvier, Bruno Pradines, Carole Houdoin, Daniel Parzy, Janina Karolak-Wojciechowska, Jacques Barbe.   

Abstract

To suggest a mechanism of action for drugs capable to reverse the chloroquine resistance, a new set of 9,10-dihydro-9,10-ethano and ethenoanthracene derivatives was synthesized and compounds were tested with the aim to assess their effect on chloroquine susceptibility in Plasmodium falciparum resistant strains. With respect to this, reversal of resistance and change in drug accumulation were compared. Structure-activity relationship and molecular modeling studies made it possible to define a pharmacophoric moiety for reversal agents and to propose a putative model of interaction with some selected amino acids.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12109904     DOI: 10.1021/jm011046l

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

Review 1.  Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.

Authors:  Robert L Summers; Megan N Nash; Rowena E Martin
Journal:  Cell Mol Life Sci       Date:  2012-06       Impact factor: 9.261

2.  Polymorphism in plasmodium falciparum drug transporter proteins and reversal of in vitro chloroquine resistance by a 9,10-dihydroethanoanthracene derivative.

Authors:  Julie Millet; Sandrine Alibert; Marylin Torrentino-Madamet; Christophe Rogier; Christiane Santelli-Rouvier; Patricia Bigot; Joel Mosnier; Eric Baret; Jacques Barbe; Daniel Parzy; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

3.  Design, Synthesis and Biochemical Evaluation of Novel Ethanoanthracenes and Related Compounds to Target Burkitt's Lymphoma.

Authors:  Andrew J Byrne; Sandra A Bright; James P McKeown; John E O'Brien; Brendan Twamley; Darren Fayne; D Clive Williams; Mary J Meegan
Journal:  Pharmaceuticals (Basel)       Date:  2020-01-17

4.  Dihydroethanoanthracene derivatives as in vitro malarial chloroquine resistance reversal agents.

Authors:  Julie Millet; Marylin Torrentino-Madamet; Sandrine Alibert; Christophe Rogier; Christiane Santelli-Rouvier; Joel Mosnier; Eric Baret; Jacques Barbe; Daniel Parzy; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

5.  Multiple drugs compete for transport via the Plasmodium falciparum chloroquine resistance transporter at distinct but interdependent sites.

Authors:  Sebastiano Bellanca; Robert L Summers; Max Meyrath; Anurag Dave; Megan N Nash; Martin Dittmer; Cecilia P Sanchez; Wilfred D Stein; Rowena E Martin; Michael Lanzer
Journal:  J Biol Chem       Date:  2014-11-06       Impact factor: 5.157

6.  Synthesis and transformations of di-endo-3-aminobicyclo-[2.2.2]oct-5-ene-2-carboxylic acid derivatives.

Authors:  Márta Palkó; Pál Sohár; Ferenc Fülöp
Journal:  Molecules       Date:  2011-09-07       Impact factor: 4.411

7.  Discovery of a selective, safe and novel anti-malarial compound with activity against chloroquine resistant strain of Plasmodium falciparum.

Authors:  Ankita Agarwal; Sarvesh Paliwal; Ruchi Mishra; Swapnil Sharma; Anil Kumar Dwivedi; Renu Tripathi; Sarika Gunjan
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

Review 8.  Dual-functioning antimalarials that inhibit the chloroquine-resistance transporter.

Authors:  Timothy J Egan; David Kuter
Journal:  Future Microbiol       Date:  2013-04       Impact factor: 3.165

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.